González-Martín, A J <br/><br/>
Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2005 
 - 749-55 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdi147  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carboplatin--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Confidence Intervals<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Ovarian Neoplasms--mortality<br/>Ovariectomy--methods<br/>Paclitaxel--administration & dosage<br/>Palliative Care<br/>Probability<br/>Prognosis<br/>Quality of Life<br/>Risk Assessment<br/>Spain<br/>Survival Analysis<br/>Treatment Outcome